• October 15, 2025
  • See all results
MedShadow Trademarked LogoBalancing the Risks and Benefits of Medications
Newsletter WEBINARS DONATE
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Health and Medical Advisory Panel
    • Podcast
    • MedShadow In The News
  • ARTICLES
    FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

    FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

    Can I Take Amiodarone (Pacerone) and Atorvastatin (Lipitor)?

    Can I Take Amiodarone (Pacerone) and Atorvastatin (Lipitor) Together?

    Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

    Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • VIDEOS
    VIDEOS
    FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

    FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

    Can I Take Amiodarone (Pacerone) and Atorvastatin (Lipitor)?

    Can I Take Amiodarone (Pacerone) and Atorvastatin (Lipitor) Together?

    Investigating Generic Drugs: How Poor Quality Generic Drugs Cause Harm

    Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

    Investigating Generic Drugs: Are Any of Us Safe from Faulty Generics?

    • Medical Animation Videos
    • Patient Story Videos
    • Nutrition Videos
  • PODCAST
    PODCAST

    Preventable Illnesses: Lifestyle Choices Over Medication

    Childhood Asthma and Obesity: The Road to Resilience

    Childhood Asthma and Obesity: The Road to Resilience

    Food As Fuel: Managing Sugar Cravings to Fight Inflammation

    Food As Fuel: Managing Sugar Cravings to Fight Inflammation

    Creativity in Veganism, and Discovering Vegan Life Balance

    Creativity in Veganism, and Discovering Vegan Life Balance

    Preventative Senior Fitness, Super-Agers, and Trusting Your Body

    Preventative Senior Fitness, Super-Agers, and Trusting Your Body

  • INFOGRAPHICS
  • Login / Signup
  • Search
Home
Meds By Symptoms
Pain
All
  • Opioids
  • Aspirin
  • NSAIDs
  • Oxycontin
  • Marijuana
  • Painkillers
  • Codeine
  • Pain Medications
  • Fentanyl
  • Pain Relief Drugs - Analgesics
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anesthetics
  • Cannabinoids (for Pain Management)
Random
  • Latest
  • Oldest
  • Random
  • A to Z

Pain

woman looking for lice on a child's head
Need to Know

Treating Lice

Suzanne B. Robotti
Opioid Painkillers
Quick Hits

Quick Hits: Cutting Back on Opioid Painkillers & More

Jonathan Block
Make Your Voice Heard In Patient-Focused Drug Development
Chronic Pain

Make Your Voice Heard In Patient-Focused Drug Development

Jonathan Block
DOJ Going After Drug Makers In Opioid Epidemic Fight
Opioid News

DOJ Going After Drug Makers In Opioid Epidemic Fight

Alanna McCatty
How CBD Treats Chronic Pain While Yielding Fewer Side Effects
Chronic Pain

How CBD Treats Chronic Pain While Yielding Fewer Side Effects

Emma Yasinski
Issues Related to HealthcareNewsFDAQuick Hits

Quick Hits: FDA Approval for New Antibiotic, ADHD Med & More

Alanna McCatty
Pharma Gifts and Doctor Prescribing
Quick Hits

Quick Hits: Pharma Gifts and Doctor Prescribing & More

Alanna McCatty
The Lowdown on NSAIDs for Pain
Drug Interactions/Side Effects

The Lowdown on NSAIDs for Pain

MedShadow
FDA Strengthening Cardiovascular, Stroke Warnings for Rx NSAIDs
News

FDA Bolsters NSAID Warnings on Heart, Stroke Risk

Jonathan Block
FDA Mandates Studies on Opioids for Chronic Pain & More
Quick Hits

Quick Hits: FDA Mandates Studies on Opioids for Pain & More

Jonathan Block
A Guide To Rheumatoid Arthritis Drugs
Featured ArticlesNew StoriesMedication Articles

A Guide To Rheumatoid Arthritis Drugs

Jeannette Moninger
Common Pain Meds Linked to Higher Risk of Heart Failure Hospitalization
News

Common NSAIDs Linked to Higher Risk of Heart Failure

MedShadow
Pros and Cons of Aspirin
Featured Articles

Pros and Cons of Aspirin

Michael Wilcox
Should Common OTC Pain Relievers Require a Prescription?
OTC

Should Common OTC Pain Relievers Require a Prescription?

Jonathan Block
NSAID Pain Relievers: A Headache for Cardiologists
Chronic Pain

NSAID Pain Relievers: A Headache for Cardiologists

Medshadow Staff
Chronic Pain

‘Doctor, I Hurt’ – Food as the Ultimate Prescription for Pain Relief

Lillie Rosenthal, DO
9 Times Ibuprofen Won't Work - and Could Be Dangerous
Media Impact: Quoted

9 Times Ibuprofen Won’t Work – and Could Be Dangerous

Suzanne B. Robotti
FDA Issues Warning on Herbal Pain Reliever Kratom
Alternative Medication

FDA Issues Warning on Herbal Pain Reliever Kratom

Alanna McCatty
News

Half of Americans Misusing Prescription Drugs, Opioids

Amanda Livingston
Physical Therapy Can Reduce Long-Term Opioid Use
Opioid News

Physical Therapy Can Reduce Long-Term Opioid Use

Jonathan Block
Load More

ABOUT MEDSHADOW

Medications have many benefits, but it’s essential to know how to balance these against their potential side effects. MedShadow is a nonprofit foundation that focuses on the safest ways to take over-the-counter (OTC) and prescription (Rx) medications. Our name derives from the fact that side effects can sometimes be difficult to recognize, which is why we work to illuminate and explain medication reactions that may be minimized or obscured.

We also help people factor in integrative health and medicine options and provide information about lifestyle changes to optimize one’s health. Whatever decision a person makes, our goal is to be supportive.

At MedShadow, our mission is to provide independent, evidence-and science-based information. Our service and investigative journalism enables people to make informed decisions and we strive to stimulate public conversation aimed at reforming the drug manufacturing processes to ensure that we are all better protected.

We do not receive any financial support from the pharmaceutical or supplement industries and we require that all our staff, writers, advisors and other partners also be free from any remunerative relationships with such companies.

SERVICES

  • ACCOUNT
    • Become an Insider
    • Login
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Medical Advisors
    • Writers
    • MedShadow In The News
  • ARTICLES
    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • PODCAST
  • VIDEOS
  • INFOGRAPHICS
  • CONTACT US
Balancing the Risks and Benefits of Medications
Copyright © 2025, MedShadow Foundation. All rights reserved. MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations. This site complies with the HONcode standard for trustworthy health information.
  • TERMS
  • ABOUT
    • About MedShadow
    • Our Team
    • Foundation Board
    • Health and Medical Advisory Panel
    • Podcast
    • MedShadow In The News
  • ARTICLES
    • New Articles
    • Health Topics
    • Conditions
    • Medications
    • Wellness
    • Culture Desk
  • VIDEOS
    • Medical Animation Videos
    • Patient Story Videos
    • Nutrition Videos
  • PODCAST
  • INFOGRAPHICS
Newsletter WEBINARS DONATE
Newsletter WEBINARS JOIN
Start typing to see results or hit ESC to close
Zyrtec PBMs Zyvox pharmacies peer review process
See all results
Username
Password
Lost password?
Create an account
Enter username or email
Cancel
x

Webinar Popup

WEBINAR #1 OF A SERIES      JUNE 25, 4:00-5:30 PM ET

Investigating Generic Drugs: How Poor Quality Generics Cause Harm

REGISTER NOW

  • Katherine EbanJournalist and Author,
    Bottle of Lies
  • David LightCo-founder and President,
    Valisure
  • Joe GraedonPresident,
    The People’s Pharmacy
  • Suzanne Robotti,Founder and President,
    MedShadow Foundation

link

x

Webinar #2